(S)-PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc

CAT:
804-HY-163215
Size:
Inquire

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(S)-PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc - image 1

(S)-PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc

  • UNSPSC Description:

    (S)-PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc is a conjugate of E3 ligase ligand and linker, consisting of (S,R,S)-AHPC (HY-125845) and the corresponding Linker. (S,R,S)-AHPC is a VH032-based von Hippel-Lindau (VHL) ligand that recruits VHL proteins. (S)-PROTAC PTK6 ligand-O-4,4-dimethylpiperidine-Boc can be used as a key intermediate for the synthesis of complete PROTAC molecules.
  • Target Antigen:

    E3 Ligase Ligand-Linker Conjugates
  • Type:

    Reference compound
  • Related Pathways:

    PROTAC
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    cancer
  • Assay Protocol:

    https://www.medchemexpress.com/s-protac-ptk6-ligand-o-4-4-dimethylpiperidine-boc.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C([C@H]1N(C[C@@H](C1)O)C([C@@H](C(C)C)C2=CC(OCC3(CCN(CC3)C(OC(C)(C)C)=O)C)=NO2)=O)NCC(C=C4)=CC=C4C(SC=N5)=C5C
  • Molecular Weight:

    695.87
  • References & Citations:

    [1]Burslem GM, et al. Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-mediated Targeted Protein Degradation. Cancer Res. 2019 Jul 16. pii: canres.1236.2019.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported